Veracyte, Inc. (VCYT)
40.49
-0.70
(-1.70%)
USD |
NASDAQ |
May 07, 15:42
Veracyte EPS Diluted (Quarterly) : 0.353 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3058 |
| Interpace Biosciences, Inc. | 0.8178 |
| Thermo Fisher Scientific, Inc. | 4.426 |
| XWELL, Inc. | -3.036 |
| Hypha Labs, Inc. | -0.0034 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 28.71M |
| Revenue (Quarterly) | 139.07M |
| Total Expenses (Quarterly) | 110.36M |
| Enterprise Value | 2.887B |
| Gross Profit Margin (Quarterly) | 72.32% |
| Profit Margin (Quarterly) | 20.64% |
| Earnings Yield | 2.68% |
| Operating Earnings Yield | 2.69% |
| Normalized Earnings Yield | 2.785 |